Open -Label,Cross Over Trail Evaluating the Glycemic Impact of Peach Varieties in Healthy Adullts

ConditionBlood Glucoe
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorRehman Medical Institute - RMI

About this trial

This study aims to evaluate the effect of different peach varieties on the glycemic index (GI) in healthy adult participants. While peaches are generally classified as low-GI fruits, variations in sugar composition, fiber content, and ripeness among different cultivars may influence their glycemic response. By assessing and comparing the GI values of several commonly consumed peach varieties, this trial seeks to provide more precise dietary recommendations for glycemic control and support better fruit selection for individuals managing blood glucose levels.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

BMI between 18.5-24.9 kg/m²

Normal fasting blood glucose (<100 mg/dL)

Willingness to adhere to the study protocol

Disqualifiers

Use of medications or supplements that affect glucose levels

Allergy to peaches or intolerance to test/reference foods

Pregnant or breastfeeding women

Smoking or use of recreational drugs

Trial design

Design model

Single group

Treatments tested in this trial

  • EARLY GRAND

    Other intervention

    Participants will consume a standardized portion of peach variety A containing 50 grams of available carbohydrates. Capillary blood glucose levels will be measured at multiple time points post-consumption to assess glycemic response.

  • SPRING CREST PEACH

    Other intervention

    Participants will consume a standardized portion of peach variety B containing 50 grams of available carbohydrates. Capillary blood glucose levels will be measured at multiple time points post-consumption to assess glycemic response.

  • INDIAN BLOOD

    Other intervention

    Participants will consume a standardized portion of peach variety C containing 50 grams of available carbohydrates. Capillary blood glucose levels will be measured at multiple time points post-consumption to assess glycemic response.

Treatment groups

16 Participants
are divided into 1 treatment group
Group A: Single group (cross over)Active comparator 3 interventions

Trial outcomes

Primary outcomes

1

Glycemic Index

Participants will consume a standardized portion of a peach variety containing 50 grams of available carbohydrates. Capillary blood glucose levels will be measured at multiple time points post-consumption to assess glycemic response.

Time frame
2 hours post-consumption (per intervention)

Secondary outcomes

1

Incremental Area Under the Curve (iAUC) for Blood Glucose

The iAUC will be calculated for each intervention using the trapezoidal method, excluding values below baseline. This helps quantify the glycemic response.

Time frame
0-120 minutes post-consumption
2

Peak Blood Glucose Concentration

The highest recorded blood glucose concentration during the 2-hour postprandial period following consumption of each intervention.

Time frame
0-120 minutes post-consumption

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: